ITGAL and progressive multifocal leukoencephalopathy: Previously, PML was also seen in patients with psoriasis treated with efalizumab, an immunomodulatory monoclonal antibody against CD11a present in T cells.8 This drug was withdrawn from the market due to PML side effects.